FUNDAMENTALS OF MS CARE – PART 3: CURRENT AND EMERGING THERAPIES AND SYMPTOM MANAGEMENT
Session 3 of Fundamentals offers an insight into multidisciplinary considerations to include DMTs, practical nursing approaches to...
PRACTICAL CONSIDERATIONS IN RELAPSE MANAGEMENT AND DISEASE MODIFYING THERAPY (DMT) APPLICATIONS
Using case-based presentations, this program will assist Advanced Practice Clinicians (APC: PA & NP) in defining what constitutes an...
CHOICES & CONTROVERSIES IN MS MANAGEMENT: A PRO/CON CASE-BASED DISCUSSION
This interactive case-based symposium will highlight contemporary controversies in MS disease management. Three debates will be moderated...
OPTIMIZING MS TREATMENT: WHAT YOUR MS CLINIC IS MISSING
The course will focus on the many ways in which the addition of a clinical pharmacy specialist to the Neurology interdisciplinary team can...
Identifying and Characterizing Fatigue in Patients Diagnosed with Multiple Sclerosis on Disease-Modifying Therapies Using Real World Evidence
Background: Fatigue is a common symptom in patients with Multiple Sclerosis (MS). Payor databases represent an important source of real...
The Importance of Specialty Pharmacy Services in Multiple Sclerosis Patient Care
Background: Johns Hopkins Specialty Pharmacy provides clinical services for eligible multiple sclerosis (MS) patients on oral and...
Evaluating the Impact of Fatigue Symptoms on Work Productivity and Activity Impairment Using Longitudinal Data from the Phase III Optimum Study
Background: Fatigue is a common symptom experienced by patients with Multiple Sclerosis (MS); and, the impact of fatigue on work...
Assessing the Impact of Disease Activity and Fatigue Symptom on Work Productivity and Activity Impairment in Patients with Relapsing Multiple Sclerosis
Background: Multiple Sclerosis (MS) is well known to reduce work productivity and adversely affect usual activities. Although previous...